Home > Compound List > Compound details
520-27-4 molecular structure
click picture or here to close

5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4H-chromen-4-one

ChemBase ID: 72938
Molecular Formular: C28H32O15
Molecular Mass: 608.54468
Monoisotopic Mass: 608.17412032
SMILES and InChIs

SMILES:
[C@@H]1([C@H]([C@@H](O[C@H]([C@@H]1O)C)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)Oc1cc2c(c(c1)O)c(=O)cc(o2)c1cc(c(cc1)OC)O)O)O)O)O)O
Canonical SMILES:
COc1ccc(cc1O)c1cc(=O)c2c(o1)cc(cc2O)O[C@@H]1O[C@H](CO[C@@H]2O[C@@H](C)[C@@H]([C@H]([C@H]2O)O)O)[C@H]([C@@H]([C@H]1O)O)O
InChI:
InChI=1S/C28H32O15/c1-10-21(32)23(34)25(36)27(40-10)39-9-19-22(33)24(35)26(37)28(43-19)41-12-6-14(30)20-15(31)8-17(42-18(20)7-12)11-3-4-16(38-2)13(29)5-11/h3-8,10,19,21-30,32-37H,9H2,1-2H3/t10-,19+,21-,22+,23+,24-,25+,26+,27+,28+/m0/s1
InChIKey:
GZSOSUNBTXMUFQ-YFAPSIMESA-N

Cite this record

CBID:72938 http://www.chembase.cn/molecule-72938.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4H-chromen-4-one
IUPAC Traditional name
5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4H-chromen-4-one
diosmin
Synonyms
Diosmetin 7-rutinoside
Daflon
Ven-Detrex
Salinigricoflavonoloside
Barosmin;
Diosmin
3′,5,7-Trihydroxy-4′-methoxyflavone 7-rutinoside
Diosmin
3′,5,7-三羟基-4′-甲氧基黄酮 7-芸香糖甙
地奥司明
CAS Number
520-27-4
EC Number
208-289-7
MDL Number
MFCD00009772
PubChem SID
24893763
162037858
PubChem CID
5281613
ATC CODE
C05CA03
CHEMBL
231884
Chemspider ID
4444932
KEGG ID
D07858
Unique Ingredient Identifier
7QM776WJ5N
Wikipedia Title
Diosmin

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem
Acid pKa 8.475596  H Acceptors 15 
H Donor LogD (pH = 5.5) -0.4434314 
LogD (pH = 7.4) -0.47794226  Log P -0.4429759 
Molar Refractivity 142.3911 cm3 Polarizability 56.485394 Å3
Polar Surface Area 234.29 Å2 Rotatable Bonds
Lipinski's Rule of Five false 

PROPERTIES

PROPERTIES

Safety Information Pharmacology Properties Product Information Bioassay(PubChem)
Storage Condition
-20°C expand Show data source
MSDS Link
Download expand Show data source
Download expand Show data source
Download expand Show data source
German water hazard class
3 expand Show data source
Personal Protective Equipment
Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter expand Show data source
Storage Temperature
2-8°C expand Show data source
Mechanism of Action
Reduces the expression of endothelial adhesion molecules (ICAM1, VCAM1), and inhibits the adhesion, migration, and activation of leukocytes at the capillary level. expand Show data source
This leads to a reduction in the release of inflammatory mediators, principally oxygen free radicals and prostaglandins (PGE2, PGF2a). expand Show data source
Purity
≥90% (HPLC) expand Show data source
90% expand Show data source
Grade
analytical standard expand Show data source
technical grade expand Show data source
Salt Data
Free Base expand Show data source
Impurities
≤10% water expand Show data source
Biological Source
Isol. from Zanthoxylum avicennae, Diosma crenulata and others, first isol. from parsley expand Show data source
Shelf Life
(limited shelf life, expiry date on the label) expand Show data source
Application(s)
Antihaemorrhagic expand Show data source
Bioflavonoid expand Show data source
Venotonic expand Show data source
Empirical Formula (Hill Notation)
C28H32O15 expand Show data source

DETAILS

DETAILS

Selleck Chemicals Selleck Chemicals Wikipedia Wikipedia Sigma Aldrich Sigma Aldrich
Selleck Chemicals - S2292 external link
Research Area: Cardiovascular Disease
Biological Activity:
Diosmin is a semisynthetic phlebotropic agent and a member of the flavonoid family.Diosmin prolongs the vasoconstrictor effect of norepinephrine on the vein wall, increasing venous tone, and therefore reducing venous capacitance, distensibility, and stasis. Diosmin increases the venous return and reduces venous hyperpressure present. Diosmin improves lymphatic drainage by increasing the frequency and intensity of lymphatic contractions, and by increasing the total number of functional lymphatic capillaries. Furthermore, diosmin with hesperidine decreases the diameter of lymphatic capillaries and the intralymphatic pressure. [1]
Sigma Aldrich - 245313 external link
Biochem/physiol Actions
Citrus flavonoid. Modification of hesperidin. Studied for its chemopreventive properties, including anti-proliferative and anti-inflammatory.
Sigma Aldrich - 61386 external link
Biochem/physiol Actions
Citrus flavonoid. Modification of hesperidin. Studied for its chemopreventive properties, including anti-proliferative and anti-inflammatory.
Sigma Aldrich - D3525 external link
Frequently Asked Questions
Live Chat and Frequently Asked Questions are available for this Product.
Biochem/physiol Actions
Citrus flavonoid. Modification of hesperidin. Studied for its chemopreventive properties, including anti-proliferative and anti-inflammatory.

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • • http://en.wikipedia.org/wiki/Diosmin
  • • Aldrich Library of FT-IR Spectra, 1st edn., 1985, 2, 98C, (ir)
  • • Lovecy, A. et al., J.C.S., 1930, 817, (synth)
  • • Arthur, H.R. et al., J.C.S., 1956, 632, (Diosmin)
  • • Horowitz, R.M. et al., J.O.C., 1956, 21, 1184, (isol)
  • • Booth, A.N. et al., J. Biol. Chem., 1958, 230, 661, (metab)
  • • Rsler, H. et al., J.O.C., 1965, 30, 4346, (pmr)
  • • Plouvier, V., C. R. Hebd. Seances Acad. Sci. Ser. D, 1966, 263, 439, (isol, struct)
  • • Brieskorn, C.H. et al., Arch. Pharm. (Weinheim, Ger.), 1971, 304, 557, (isol)
  • • Wagner, H. et al., Tet. Lett., 1976, 1799, (cmr)
  • • Oustrin, J. et al., Arzneim.-Forsch., 1977, 27, 1688, (pharmacol)
  • • Le Quesne, P.W. et al., J.C.S. Perkin 1, 1978, 1572, (isol, uv, pmr)
  • • Itokawa, H. et al., Chem. Lett., 1982, 1, 49, (ms)
  • • Fujita, M. et al., Chem. Pharm. Bull., 1982, 30, 1151, (cmr)
  • • Martindale, The Extra Pharmacopoeia, 28th/29th edn., Pharmaceutical Press, 1982, 12667
  • • Voigtlnder, H.W. et al., Arch. Pharm. (Weinheim, Ger.), 1983, 316, 219, (synth)
  • • Voirin, B., Phytochemistry, 1983, 22, 2107, (uv)
  • • Rashid, M.A. et al., Fitoterapia, 1995, 66, 471, (Diosmin, pmr, cmr)
  • • Bergan, J.J. et al., Angiology, 2001, 52, S43-S47, (diosmin, rev)
  • • Garner, R.C. et al., J. Pharm. Sci., 2002, 91, 32-40, (diosmin, pharmacol)
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle